Hedenmalm, Karin http://orcid.org/0000-0002-9544-9163
Pacurariu, Alexandra
Slattery, Jim
Kurz, Xavier
Candore, Gianmario
Flynn, Rob
Article History
Accepted: 26 May 2021
First Online: 17 July 2021
Declarations
:
: No sources of funding were used to assist in the preparation of this article.
: Karin Hedenmalm, Alexandra Pacurariu, Jim Slattery, Xavier Kurz, Gianmario Candore and Rob Flynn are employees of the European Medicines Agency and have no conflicts of interest to declare in relation to this article.
: This study was carried out using a deanonymized database (IMS<sup>®</sup> Disease Analyzer Germany), for which ethics approval was not required.
: Not applicable.
: Not applicable.
: Not applicable.
: The analyses conducted in this study were performed by the authors based on the IMS<sup>®</sup> Disease Analyzer Germany database, version June 2019. The study has been registered in the EUPAS register (EUPAS 31864). Analytic data sets and custom codes can be made available upon request from the authors.
: All authors contributed to the study design and analysis of results. Karin Hedenmalm drafted the manuscript with contributions from all other authors. All authors read and approved the final version.
: The views expressed in this article are the personal views of the authors and may not be understood or quoted as being made on behalf of, or reflecting the position of, the European Medicines Agency or one of its committees or working parties.